Drug Target Review – Issue #1 2017

Posted: 9 March 2017 | | No comments yet

Included in this issue: Importance of building patient trust; Vaccines & Immunology; Oncology; Assays; Biomarkers; and Antibodies…

Drug Target Review magazine Issue #1 2017 spread
  • Foreword: The importance of building patient trust
    Pamela Brankin, Head of Marketing and Communications, Aridhia
  • In-Depth Focus: Assays
  • Vaccines & Immunology: Bispecific antibodies Q&A
    Lou Matis, Chief Development Officer at Pieris
  • In-Depth Focus: Antibodies
  • Oncology: Targeting GAS6 in cancer, fibrosis and viral infection
    Rebecca Miao and Amato J. Giaccia, Stanford University, and Raymond Tabibiazar, Aravive Biologics
  • Oncology: Nanoparticle-mediated enzyme delivery for application in cancer therapy
    Negin Mokhtari, Mukanth Vaidyanathan, Ya-San Yeh, and Sadik Esener, University of California, San Diego
  • In-Depth Focus: Biomarkers

The digital version of Issue #1 2017 is restricted - login or subscribe free to access

DTR Issue 1 2023Thank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here